ArticleInternational journal of women's health2026
Clinical and Metabolic Factors Associated with Comorbidities of Thyroid and Breast Diseases in Women Aged 25-55 Years.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer and thyroid cancer are common malignancies in Chinese women. The incidence and mortality rates of both cancers are increasing, seriously endangering the health of Chinese women. The association between these two diseases has drawn attention, yet research focusing on their comorbidity remains relatively limited. Methods: We conducted a secondary analysis of data collected from a study that examined the health status of 17,086 women aged 25-55 years who underwent physical examinations at a tertiary hospital in China. Results: The results showed that nearly half of the women had comorbidities. Age, BMI, hypertension, diabetes, uterine fibroids, lung disease, liver disease and kidney disease differed among the three groups of women, ie, those without thyroid or breast disease, those with a single thyroid/breast disease, and those with thyroid-breast comorbidity (all P < 0.05). Hypertension (OR = 1.434, 95% CI: 1.063-1.934), overweight or obesity (OR = 1.472, 95% CI: 1.211-1.788), kidney disease (OR = 1.424, 95% CI: 1.161-1.747), and uterine fibroids (OR = 2.542, 95% CI: 1.879-3.439) were associated factors for thyroid-breast comorbidity in women. Conclusion: Based on the comorbidity characteristics of thyroid and breast diseases, this study aims to integrate thyroid disease and breast disease, dissect the current status of comorbidity in the Chinese female population, and further explore associated factors to provide more accurate and systematic countermeasures for improving women's health.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.